Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Income (2020 - 2024)

Roivant Sciences' Net Income history spans 5 years, with the latest figure at $327.0 million for Q4 2024.

  • For Q4 2024, Net Income rose 658.87% year-over-year to $327.0 million; the TTM value through Sep 2025 reached $327.0 million, up 2715.11%, while the annual FY2025 figure was $373.2 million, 218.42% up from the prior year.
  • Net Income reached $327.0 million in Q4 2024 per ROIV's latest filing, up from -$43.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $327.0 million in Q4 2024 to a low of -$384.9 million in Q4 2022.
  • Average Net Income over 5 years is -$141.6 million, with a median of -$101.1 million recorded in 2021.
  • Peak YoY movement for Net Income: tumbled 1167.12% in 2021, then surged 658.87% in 2024.
  • A 5-year view of Net Income shows it stood at -$275.6 million in 2020, then decreased by 11.06% to -$306.1 million in 2021, then dropped by 25.75% to -$384.9 million in 2022, then skyrocketed by 84.8% to -$58.5 million in 2023, then soared by 658.87% to $327.0 million in 2024.
  • Per Business Quant, the three most recent readings for ROIV's Net Income are $327.0 million (Q4 2024), -$43.1 million (Q3 2024), and $89.1 million (Q2 2024).